May 26, 2020
Health System in Pandemic Epicenter Identifies Outcomes and New Risk Factors of Patients Hospitalized with COVID-19
Apr 29, 2020
LifeNome Launches COVID-19 Severity Predisposition Assessment and Risk Evaluator (SPARE)
Nov 12, 2019
Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the U.S. Community Practices
Oct 03, 2018
Five Years of Patient Registry Success: NORD's IAMRARE(TM) Registry Program Celebrates New Partnerships and Models of Engagement
Sep 19, 2018
Primary Immunodeficiency Diseases Epiomic Epidemiology Markets, 2018-2028 - Focus on 23 Key Countries
Sep 19, 2018
Alpha-1 Anti-Trypsin Deficiency Epiomic Epidemiology Forecasts 2018-2028
Sep 19, 2018
Cushing's Syndrome Epiomic Epidemiology Forecast 2018-2028 by Gender and 5-Year Age Cohort
Aug 10, 2018
Peripheral Arterial Disease Forecasts In 22 Major Markets 2018-2028 - Risk Factors, Disease Diagnosis and Prognosis Along with Specific Variations by Geography and Ethnicity
Aug 10, 2018
Tay-Sachs Disease Forecast In 19 Major Markets 2018-2028: Risk Factors, Disease Diagnosis and Prognosis Along with Specific Variations by Geography and Ethnicity
Aug 08, 2018
Hypertension Epidemiology Forecast In 19 Major Markets 2018 - 10 Year Snapshot to 2028
Jul 16, 2018
Fabry Disease Markets 2018-2028 by Gender and 5-Year Age Cohort
Apr 25, 2018
Global Rett Syndrome Epiomic Epidemiology Report 2018: 10 year Forecasts for 23 Major Markets
Apr 24, 2018
Global Huntington's Disease Forecasts 2018-2028 by Gender and 5-Year Age Cohort
Jan 12, 2018
Primary Carnitine Deficiency Forecasts Report 2018-2028: Key Comorbid Conditions / Features Associated With the Disease
Dec 18, 2017
Parkinson's Disease Market Forecasts 2018-2028 by Gender and 5-Year Age Cohort
Dec 18, 2017
Lower Urinary Tract Symptoms Markets to 2028
Dec 18, 2017
Chronic Heart Failure Forecasts to 2028: Quantify Patient Populations in the Global Chronic Heart Failure Market to Target the Development of Future Products, Pricing Strategies and Launch Plans
Oct 24, 2017
DRG launches Patient Profiler, dramatically advancing the understanding of patient-level drivers in rheumatoid arthritis
Oct 09, 2017
Mallinckrodt Will Conduct Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Symptomatic Sarcoidosis